Altamira Therapeutics Financial Overview
Altamira Therapeutics's market cap is currently $485.81K. The company's EPS TTM is $-0.306; its P/E ratio is -0.07; Altamira Therapeutics is scheduled to report earnings on August 29, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
